Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro
F1000Research · 26.03.2026 · 15 · 68
DOI: 10.12688/f1000research.173746.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 26.03.2026. Verfasst von Rana Alfardan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was partially supported by Southern Technical University under scientific research awards.
Abstract (Originalsprache)
Background
Pancreatic cancer has a poor prognosis and is highly aggressive and deadly. Most pancreatic cancer diagnoses are adenocarcinomas, which account for more than 90 % of all cases. Developing effective therapeutic strategies requires an understanding of the molecular mechanisms associated with pancreatic cancer progression. Small nucleolar RNA 64 (SNORA64) was presented as a predictive marker for pancreatic cancer stages in our previous study. SNORA64 showed a gradual loss of its expression throughout the carcinogenesis process, and it inhibited metastasis by interfering with epithelial to mesenchymal transition (EMT). In this study, we investigated the role of SNORA64 on an intrinsic apoptotic pathway in pancreatic cancers by using human pancreatic cell line derived from adenocarcinoma PK-8 with SNORA64 knockdown and the scramble to compare with.
Methods
QPCR techniques used to measure the gene expression level of apoptosis related genes and cell viability assay using trypan blue exclusion are implanted in this study as investigational methods.
Results
Pk-8 SNORA64 knockdown shows a significant low expression of tumor suppressor P53 in contrast to the scramble control cell line. Pk-8 SNORA64 knockdown shows significantly high expression of anti-apoptotic genes B-cell leukemia/lymphoma-2 (BCl2) and B-cell lymphoma-extra-large (BCL-Xl) in contrast to the scramble control cell line. Conversely, the pro-apoptotic genes BH3 interacting domain death agonist (BID), BCL2 Associated X (BAX), and BCL2 homologous antagonist/killer (BAK) show significantly low expression compared to the scramble control. However, there is no change in the expression of BAD and BIM in Pk-8 with SNORA64 knockdown compared to the scrambled control cell line. Furthermore, the Pk-8 with SNORA64 knockdown shows a significant high proliferation rate and viability percentage compared to the scramble control cell line.
Conclusion
The downregulation of SNORA64 affects apoptosis pathways by manipulating pro- and anti-apoptotic gene regulators. The SNORA64 interactions with apoptotic inhibitor molecules and downregulation of pro-apoptotic molecules significantly sustain cellular viability. Therefore; SNORA64 may serve as a sensitizer to apoptosis-inducing therapies.
Förderung
- This work was partially supported by Southern Technical University under scientific research awards
Zitieren
APA
Alfardan, R. (2026). Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. F1000Research, 15, 68. https://doi.org/10.12688/f1000research.173746.2
Vancouver
Alfardan R. Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. F1000Research. 2026;15:68. doi:10.12688/f1000research.173746.2
BibTeX
@article{Alfardan2026,
author = {Alfardan, Rana},
title = {Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro},
journal = {F1000Research},
year = {2026},
volume = {15},
pages = {68},
doi = {10.12688/f1000research.173746.2}
}
EUVIMED